skip to the main content

Golimumab

Measuring Golimumab drug concentrations in patients being treated with Golimumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Golimumab allows for reliable measurement of Golimumab drug levels using just a small amount of human serum, plasma, or whole blood, delivering results in 10 minutes. This allows clinicians to confirm the drug levels of Golimumab immediately before the next administration.

  • CE

Available Instruments

About Using Reagent

  • Sample Types

    Whole blood, Serum, Plasma
  • Reaction Time

    10 mins
  • Detection Range

    0.20-30 μg/mL
  • Intended Use

    Quantitative determination of free Golimumab in human whole blood/serum/plasma

In Your Medical Field

AFIAS Golimumab measures Golimumab drug levels in patients' blood, using whole blood, serum, or plasma samples. This allows clinicians to obtain TDM results within just 10 minutes. It provides valuable insights into patients’ response to the treatment of Golimumab.